Literature DB >> 31818925

Hypoxanthine-Guanine Phosphoribosyltransferase Is Dispensable for Mycobacterium smegmatis Viability.

Zdeněk Knejzlík1, Klára Herkommerová1, Dana Hocková1, Iva Pichová2.   

Abstract

Purine metabolism plays a ubiquitous role in the physiology of Mycobacterium tuberculosis and other mycobacteria. The purine salvage enzyme hypoxanthine-guanine phosphoribosyltransferase (HGPRT) is essential for M. tuberculosis growth in vitro; however, its precise role in M. tuberculosis physiology is unclear. Membrane-permeable prodrugs of specifically designed HGPRT inhibitors arrest the growth of M. tuberculosis and represent potential new antituberculosis compounds. Here, we investigated the purine salvage pathway in the model organism Mycobacterium smegmatis Using genomic deletion analysis, we confirmed that HGPRT is the only guanine and hypoxanthine salvage enzyme in M. smegmatis but is not required for in vitro growth of this mycobacterium or survival under long-term stationary-phase conditions. We also found that prodrugs of M. tuberculosis HGPRT inhibitors displayed an unexpected antimicrobial activity against M. smegmatis that is independent of HGPRT. Our data point to a different mode of mechanism of action for these inhibitors than was originally proposed.IMPORTANCE Purine bases, released by the hydrolytic and phosphorolytic degradation of nucleic acids and nucleotides, can be salvaged and recycled. The hypoxanthine-guanine phosphoribosyltransferase (HGPRT), which catalyzes the formation of guanosine-5'-monophosphate from guanine and inosine-5'-monophosphate from hypoxanthine, represents a potential target for specific inhibitor development. Deletion of the HGPRT gene (Δhgprt) in the model organism Mycobacterium smegmatis confirmed that this enzyme is not essential for M. smegmatis growth. Prodrugs of acyclic nucleoside phosphonates (ANPs), originally designed against HGPRT from Mycobacterium tuberculosis, displayed anti-M. smegmatis activities comparable to those obtained for M. tuberculosis but also inhibited the Δhgprt M. smegmatis strain. These results confirmed that ANPs act in M. smegmatis by a mechanism independent of HGPRT.
Copyright © 2020 American Society for Microbiology.

Entities:  

Keywords:  Mycobacterium smegmatis; guanine; hypoxanthine; hypoxanthine-guanine phosphoribosyltransferase; inhibitors; purine salvage pathway

Year:  2020        PMID: 31818925      PMCID: PMC7015712          DOI: 10.1128/JB.00710-19

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  27 in total

1.  Mycobacterium smegmatis and tuberculosis.

Authors:  Jaya Sivaswami Tyagi; Deepak Sharma
Journal:  Trends Microbiol       Date:  2002-02       Impact factor: 17.079

2.  Electroporation of mycobacteria.

Authors:  Renan Goude; David M Roberts; Tanya Parish
Journal:  Methods Mol Biol       Date:  2015

3.  Antimicrobial susceptibility testing for Mycobacterium sp.

Authors:  Delia Blanco-Ruano; David M Roberts; Ruben Gonzalez-Del-Rio; Daniel Álvarez; Ma José Rebollo; Esther Pérez-Herrán; Alfonso Mendoza
Journal:  Methods Mol Biol       Date:  2015

4.  A purF mutant of Mycobacterium smegmatis has impaired survival during oxygen-starved stationary phase.

Authors:  Jacquie Keer; Marjan J Smeulders; Huw D Williams
Journal:  Microbiology (Reading)       Date:  2001-02       Impact factor: 2.777

5.  Pyrrolidine nucleoside bisphosphonates as antituberculosis agents targeting hypoxanthine-guanine phosphoribosyltransferase.

Authors:  Wai Soon Eng; Dominik Rejman; Radek Pohl; Nicholas P West; Kyra Woods; Lieve M J Naesens; Dianne T Keough; Luke W Guddat
Journal:  Eur J Med Chem       Date:  2018-09-19       Impact factor: 6.514

6.  Biosynthesis of nucleic acid purines in Mycobacterium tuberculosis H37Rv.

Authors:  V G Malathi; T Ramakrishnan
Journal:  Biochem J       Date:  1966-02       Impact factor: 3.857

7.  Isolation and characterization of efficient plasmid transformation mutants of Mycobacterium smegmatis.

Authors:  S B Snapper; R E Melton; S Mustafa; T Kieser; W R Jacobs
Journal:  Mol Microbiol       Date:  1990-11       Impact factor: 3.501

8.  Biosynthesis and scavenging of purines by pathogenic mycobacteria including Mycobacterium leprae.

Authors:  P R Wheeler
Journal:  J Gen Microbiol       Date:  1987-11

9.  Inhibition of hypoxanthine-guanine phosphoribosyltransferase by acyclic nucleoside phosphonates: a new class of antimalarial therapeutics.

Authors:  Dianne T Keough; Dana Hocková; Antonín Holý; Lieve M J Naesens; Tina S Skinner-Adams; John de Jersey; Luke W Guddat
Journal:  J Med Chem       Date:  2009-07-23       Impact factor: 7.446

10.  High-resolution phenotypic profiling defines genes essential for mycobacterial growth and cholesterol catabolism.

Authors:  Jennifer E Griffin; Jeffrey D Gawronski; Michael A Dejesus; Thomas R Ioerger; Brian J Akerley; Christopher M Sassetti
Journal:  PLoS Pathog       Date:  2011-09-29       Impact factor: 6.823

View more
  1 in total

Review 1.  Phosphonates and Phosphonate Prodrugs in Medicinal Chemistry: Past Successes and Future Prospects.

Authors:  Marcela Krečmerová; Pavel Majer; Rana Rais; Barbara S Slusher
Journal:  Front Chem       Date:  2022-05-20       Impact factor: 5.545

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.